← FDA Drug Approvals (Drugs@FDA)
BOSENTAN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA LTD · Approved 2019-04-26
Drug application
- FDA Application #
ANDA206987- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BOSENTAN
- Generic name
- Bosentan
- Active ingredients
- BOSENTAN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- NATCO PHARMA LTD
- First approval
- 2019-04-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown